Herpes Zoster in Psoriasis and Psoriatic Arthritis: Incidence and Prevention - 2019 On Demand Webinar
Hear from Dr. Joseph Merola and Dr. Emily Baumrin on the latest information regarding the herpes zoster vaccine and psoriatic disease.
If you do not yet have an account with the national psoriasis foundation, please click here to create a new account prior to taking this course. Thank you!
This program is supported by an unrestricted educational grant from Celgene Corporation.
The National Psoriasis Foundation is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The National Psoriasis Foundation designates this enduring material for a maximum of .50 AMA PRA Category 1 Credit(s) TM. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Physicians, Dermatologists, Rheumatologists, and Allied Healthcare professionals.
- Compare the risk of herpes zoster in patients with psoriasis and psoriatic arthritis on different systemic therapies including conventional synthetic, biologic, and targeted synthetic disease modifying antirheumatic drugs.
- Review the new recombinant zoster vaccine and recommendations for vaccination in patients with psoriasis and psoriatic arthritis.
Questions? Contact us at firstname.lastname@example.org or 503-546-8387
Joseph Merola, M.D., MMSc
Associate Professor, Harvard Medical School
Director of the Clinical Unit for Research Innovation and Trials
Director, Center for Skin and Related Musculoskeletal Diseases
Department of Dermatology and Department of Medicine, Division of Rheumatology
Associate Program Director, Combined Internal Medicine-Dermatology Residency Program
Brigham and Women's Hospital, Boston, MA
Emily Baumrin, MD
Internal Medicine and Dermatology Resident
Harvard Medical School